MIRA INFORM REPORT

 

 

Report Date :

09.03.2007

 

IDENTIFICATION DETAILS

 

Name :

ESKAY FINE CHEMICALS DIVISION OF S KANT PHARMA PRIVATE LIMITED

 

 

Registered Office :

Plot No. 7, Turbhe, Thane – Belapur Road, Navi Mumbai – 400 705, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

14.06.1983

 

 

Com. Reg. No.:

11-30195

 

 

CIN No.:

[Company Identification No.]

U24239MH1983PTC030195

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME04859B

 

 

PAN No.:

[Permanent Account No.]

AAACS7439J

 

 

Legal Form :

 Private limited liability company

 

 

Line of Business :

To  carry on the business of Manufacturing, Preparing, Acquiring, Buying, Selling, Re-Selling, Importing, Exporting, Distributing, Altering, Exchanging, Improving, Storing, Inventing, Marketing or otherwise dealing in Pharmaceuticals, Drugs, Medicines, Mixtures, Vitamins, Hormones, Herbals, Chemicals, Acids, Alkalies and Essences.

 


 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 300000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of S. Kant Group, a medium sized family group.

 

Directors are reported as experienced, respectable and resourceful businessmen.

 

Their trade relations are reported as fair. Payments are reported as slow but correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

Plot No. 7, Turbhe, Thane – Belapur Road, Navi Mumbai – 400 705, Maharashtra, INDIA

Tel. No.:

91-22-23648882 / 27681505

Fax No.:

91-22-23633900

E-Mail :

skage@giasbm01.vsnl.net.in

eskay@skageexports.com

Location :

Owned

 

 

Corporate Office :

3A, Shiv Sagar Estate, North Wing, Dr. A B Road, Worli, Mumbai – 400018, Maharashtra, India

Tel. No.:

91-22-55527600

Fax No.:

91-22-55527600

 

 

DIRECTORS

 

Name

Mr. Lalitkumar P. Shah

Designation

Director

Address

B-2, Amalfi, 27/B, LD Ruparel Marg, Mumbai – 400 006, Maharashtra

Date of Birth

02.10.1936

Date of Appointment

31.03.1998

 

 

Name

Mr. Ketan L. Shah

Designation

Director

Address

B-2/2, Amalfi, 27/B, LD Ruparel Marg, Mumbai – 400 006, Maharashtra

Date of Birth

21.05.1971

Date of Appointment

07.03.1996

 

 

Name

Mr. Bipin N. Shah

Designation

Director

Address

27/5, Prakash Building No. 1, 28A Ridge Road, Mumbai – 400 006, Maharashtra

Date of Birth

07.03.1949

Date of Appointment

16.12.1985

 

 

Name

Mr. Samir J. Shah

Designation

Director

Address

18/3, Rekha No. 1, 46, Ridge Road, Mumbai – 400 006, Maharashtra

Date of Appointment

01.03.1998

 

 

Name

Mr. Jayantilal P. Shah

Designation

Director

Address

18/3, Rekha No. 1, 46, Ridge Road, Mumbai – 400 006, Maharashtra

Date of Birth

07.05.1929

Date of Appointment

01.04.2001

 

 

SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Mrudula J. Shah

 

900

Jopasha  Investment & Private Limited

 

4530

L. P. Shah Holdings & Traders Private Limited

 

7500

Lalitkumar P. Shah

 

1200

Ketan L. Shah

 

300

Samir J. Shah

 

300

Jayantilal P. Shah

 

270

Total

 

15000

 

 

BUSINESS DETAILS

 

Line of Business :

To  carry on the business of Manufacturing, Preparing, Acquiring, Buying, Selling, Re-Selling, Importing, Exporting, Distributing, Altering, Exchanging, Improving, Storing, Inventing, Marketing or otherwise dealing in Pharmaceuticals, Drugs, Medicines, Mixtures, Vitamins, Hormones, Herbals, Chemicals, Acids, Alkalies and Essences.

 

 

Products :

Microbar – 30031

Barium Sulphate – 2833

Diiodohydroxy Quinoline – 2931

 

PRODUCTION STATUS

 

Particulars

Unit

 

Installed Capacity

Pharmaceutical Bulk Drugs

Kgs.

 

420000

Pharmaceutical Formulations

-          Microbar Solids

-          Microbar Liquids

 

Kgs.

Ltr.

 

 

120000

72000

Chemicals

-          Selenium Sulphide

-          Methyl lodide/ TMSI

 

Kgs.

Kgs.

 

 

30000

96000

 

 

GENERAL INFORMATION

 

Suppliers :

·         Chemfab Alkalies Limited

·         Jaysynth Dyechem Limited

·         Tody Brothers Private Limited

·         Shriram Chemicals

·         San-Wa-Plast Private Limited

·         Indequip Limited

·         CBC Company Limited

·         China Steel Chemical Corporation

·         New Bombay Drums Company

·         Seen Ven Traders Private Limited

·         Sinochem Jiangsu Imp & Exp.

·         Shriram Chemicals

·         Chemfab Alkalis Limited

·         Capchins (India) Private Limited

·         Alankar Shipping & Clearing Private Limited

·         Magnum Clearing & Forwarding

·         Pharma Distribution (India) Private Limited

·         Ratilal Chemark Private Limited

·         S. B. R. & Company Pakistan (Private) Limited

·         Indian Radiological & Imagin

·         Omega International

·         V. M. Enterprises

 

 

Customers :

·         Exide Industries Limited

·         Cheminor Drugs Limited

·         Anita Enterprises

·         Pidilite Industries Limited

·         S. Kant Healthcare Private Limited

·         Color-Chem Limited

·         RPG Life Sciences Limited

·         Vansi Labs Limited

·         Elgomhooria Company

·         Medivision Wholesalers (Private) Limited

·         Abbott Australasia Private Limited

·         Nairobi X-Ray Supplies Limited

·         Searl Pakistan

·         Tabros Pharma

·         Pioneer Laboratories Private Limited

·         Raj Pharma Agency

·         Marpol Chemicals Limited

·         Medivision Wholesalers (Private) Limited

·         Sehgal Enterprises

·         Rege Imaging & Cinefilms (Private) Limited

·         Raj Pharma Agency

 

 

No. of Employees :

110

 

 

Bankers :

Ř       Bank of India

Ř       State Bank of India

Ř       Bank of Baroda Opera House Branch, Mumbai – 400 004, Maharashtra

 

 

Facilities :

--

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

S. I. Mogul Associates

Chartered Accountants

Address :

73-B, Mittal Court, Nariman Point, Mumbai – 400 021, Maharashtra

Tel. No.:

91-22-22842159/093

Fax No.:

91-22-22822743

E-Mail :

simogul@vsnl.net

 

 

Associates/Subsidiaries :

S. Kant Healthcare Private Limited

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

25,000

Equity Shares

Rs.100/- each

Rs. 2.500 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

15,000

Equity Shares

Rs.100/- each

Rs. 1.500 millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

 

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

1.500

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

78.803

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

80.303

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.590

2] Unsecured Loans

 

 

0.020

TOTAL BORROWING

 

 

0.610

DEFERRED TAX LIABILITIES

 

 

0.451

 

 

 

 

TOTAL

 

 

81.364

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

34.568

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

16.776

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

26.113

 

Sundry Debtors

 

 

74.076

 

Cash & Bank Balances

 

 

10.472

 

Other Current Assets

 

 

2.011

 

Loans & Advances

 

 

43.483

Total Current Assets

 

 

156.155

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

 

86.325

 

Provisions

 

 

39.916

Total Current Liabilities

 

 

126.241

Net Current Assets

 

 

29.914

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.106

 

 

 

 

TOTAL

 

 

81.364

 

KEY RATIOS

 

PARTICULARS

 

 

 

 

31.03.2006

Debt Equity Ratio

(Total Liability/Networth)

 

 

 

1.58

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

 

1.24

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

The company shifted its Registered Office to Navi Mumbai w.e.f. 21st December, 2001.

 

The company’s fixed assets of important value includes factory building, productive machinery, laboratory equipments, material storage & handling equipments, electrical installations, furniture & fixtures, vehicles, typewriters, research & development equipments, air conditioners, office equipments, motor cars, plumbing installations and computers

 

Bankers Charges Report as per Registry

 

Name of the company

S KANT PHARMA PRIVATE LIMITED

Presented By

Bank of India, Opera House Branch, Mumbai – 400004

1) Date and description of instrument creating the change

Principal Deed of Hypothecation of Tangible Movable Machinery and Plant dated 31.03.1992

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 7.800 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

All tangible movable and plant both present and future whether installed or not whether lying loose or in cases at site or in transit or which may at any time during the continuance of this security be installed or lying loose or in cases or being in or upon or about the borrower’s premises godowns at Thane / Bombay or whether to the order and disposition of the Borrower or in course or transit  to the borrower.

4) Gist of the terms and conditions and extent and operation of the charge.

Interest at the rate of 12.25 % p.a. above the Reserve Bank of India rate for Demand Loans from time to time with a minimum rate of 23.25 % p.a. or at such rate as may from time to time be fixed by the Bank and notified to the Borrower and shall be payable with quarterly rests on the 31.03, 30.06, 30.09 and 31.12 each year. 

5) Name and Address and description of the person entitled to the charge.

Bank of India, Opera House Branch, Hermes House, Parmanand Road, Mumbai – 400004

6) Date  and brief description of instrument modifying the charge

Dated 09.02.2005

Hypothecation cum loan agreement [Plant and Machinery, Stocks and Book debts]

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Past Modifications :

 

The original charge dated 31.03.1992 for Rs. 7.800 Millions has been modified form time to time as under :

On 24.04.1998 an additional sum of Rs. 14.000 Millions granted by the Bank, thereby enhancing the limit form Rs. 21.800 Millions to Rs. 24.000 Millions

 

Present Modification

 

By this modification dated 09.02.2005 the charge has been increased from Rs. 24.000 Millions to the enhanced aggregate limit of Rs. 50.000 Millions as started below :

 

Nature of Facilities

Limit Rs In Millions

Fund Based Limits

 

Preshipment

 

Cash Credit – Hyp of Stocks

10.000

Export Packing Credit

10.000

Max A (a) I & II

10.000

Post Shipment

 

Inland BP/BD [90 days]

10.000

FBP / FBN [DP/DA 150 days]

10.000

Max A (b) I & II

10.000

Total [A]

10.000

Non Fund Based Limits

 

Import L/C, DP/DA 180 days

39.000

Inland / Foreign Guarantee

1.000

Max. of B [a+b]

40.000

Max. [A+B]

50.000

 

Other terms and conditions as per Annexure ‘A’

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.22

UK Pound

1

Rs.85.27

Euro

1

Rs.58.24

 

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions